Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.
Journal: Cancer research communications
Published: May 29, 2024
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.
Journal: European journal of breast health
Published: July 17, 2023
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
Journal: Investigational new drugs
Published: January 21, 2023
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.
Journal: Cancer medicine
Published: August 21, 2021
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer.
Journal: The oncologist
Published: September 24, 2020
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 23, 2020
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
Journal: Investigational new drugs
Published: October 19, 2018
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation.
Journal: Journal of Cancer
Published: November 03, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
Journal: Breast cancer research and treatment
Published: May 25, 2016
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 23, 2015
Last Updated: 09/26/2026